Related Experiment Videos
Temperature dependent protein removal by large pore membrane filtration
M Zborowski1, P S Malchesky, Y Nosé
1Department of Artificial Organs, Cleveland Clinic Foundation, OH 44195-5132.
Summary
Cryofiltration, a novel membrane filtration technique, effectively removes cryoprecipitable proteins and immune complexes from plasma at cold temperatures. This method shows promise in reducing the need for plasma replacement products in cryoglobulinemia treatment.
Area of Science:
- Biomedical Engineering
- Nephrology
- Immunology
Background:
- Plasma exchange (PLEX) is costly and has side effects, necessitating alternative treatments.
- Cryoglobulinemia involves cryoprecipitable proteins (CPP) and immune complexes (IC) that can be targeted.
- On-line plasma fractionation offers a potential alternative to traditional PLEX.
Purpose of the Study:
- To investigate the efficacy of cold membrane filtration (cryofiltration) for removing cryoglobulins.
- To evaluate the temperature-dependent effects on cryoglobulin removal using a specific membrane filter.
- To assess the potential of cryofiltration as a cost-effective and safer alternative to PLEX.
Main Methods:
- In vitro study using a large pore (3 microns) membrane filter with a low surface area (0.14 m2).
- Filtration experiments were conducted at different temperatures (4°C and 23°C).
- Plasma from cryoglobulinemic patients with high concentrations of CPP and IC was used.
Main Results:
- Cryoglobulin removal was highly temperature-dependent, with significantly higher removal rates at 4°C.
- High removal ratios for IC and CPP were achieved, with sieving coefficients (SC) of 0.05 for CPP at 4°C.
- Albumin removal remained high across temperatures (SC = 0.94 at 4°C, 0.95 at 23°C), indicating selectivity.
Conclusions:
- Cryofiltration is a selective and effective method for removing cryoglobulins from plasma.
- The technique is capable of processing clinically relevant volumes of plasma ( > 2L).
- This high-performance cryofiltration may significantly reduce the clinical reliance on plasma replacement products.